0      0

The Journey from a Solid to a Biotech Production Site


‐ Apr 25, 2022 2:10pm


Credits: None available.

R-Pharm Germany has set up a biotechnical plant at its Illertissen site. Driven by the pandemic situation, a production area for vaccines and one for monoclonal antibodies (MAB) were established. In a very ambitious timeline, all the necessary infrastructure and supporting functions were also built.


Credits

Credits: None available.